BBG A.I CyberSecurity Scoring
01/04/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for B. Braun Group in 2026.
No incidents recorded for B. Braun Group in 2026.
No incidents recorded for B. Braun Group in 2026.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.
STERIS is a leading provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and medical device Customers. MISSION WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. VISION We strive to be a GREAT COMPANY. We provide world-class products and services for our Customers, safe and rewarding work for our people, and superior returns for our Shareholders. • $5 Billion in revenue in FY24 • More than 17,000 Associates worldwide • Over 4,000 Customer-facing professionals • Listed on the New York Stock Exchange under the symbol “STE” To learn more, visit www.steris.com. Want to join the team? View and apply for open roles at careers.steris.com.
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart. Through a spirit of ownership and can-do attitude, we work together to win.. We’re a company of people who care about each other, about our customers and their patients, and about our communities. Together, we fulfill our shared purpose of Life Unlimited. Please note: not all products referred to may be approved for use or available in all markets.
Latest updates, reports, and threat intel affecting the global network.
Press release - The Business Research Company - Analysis of Key Market Segments Driving the Bioabsorbable Surgical Mesh Market - published...
One expert said the lack of cyber attacks against the U.S. is not surprising given the internet blackouts and possible damage to Iranian...
CHICAGO (WLS) -- Following the American and Israeli strikes in Iran, federal and local law enforcement nationwide are on high alert for...
Network security statistics reveal that cyber-attacks such as breaches, leaks, and exposes affect 350+ million individuals in the U.S....
ServiceNow has acquired cybersecurity firm Armis for $7.75 billion to expand AI-powered security across medical devices.
Our picks for the hottest cybersecurity startups of 2025 include companies in key categories such as AI security and agentic-powered cyber...
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue...
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious...
Here are the worldwide cybersecurity job openings available as of August 19, 2025, including on-site, hybrid, and remote roles.
The GOOSE subscriber component improperly validates the UTC timestamp field in unauthenticated IEC 61850 GOOSE (EtherType 0x88B8) Layer-2 multicast messages. A specially crafted GOOSE frame containing an undersized timestamp field can trigger a heap out-of-bounds read during message processing, causing the process to crash and resulting in a denial-of-service condition.
OpenClaw Dashboard contains a stored cross-site scripting vulnerability that allows unauthenticated remote attackers to execute arbitrary JavaScript in the administrator's browser session by injecting HTML markup into agent transcript messages processed through the sessions API. Attackers can craft a message containing inline event handler payloads such as an img tag with an onerror attribute within the 60-character rendering budget, which is stored in the session transcript and interpolated unsanitized into innerHTML on the default landing page, allowing theft of session tokens and unauthorized calls to authenticated administrative endpoints including agent instruction file modification.
MeshCentral 1.1.21 contains a cross-site WebSocket hijacking protection bypass vulnerability that allows unauthenticated remote attackers to hijack authenticated administrator sessions by exploiting an unconditional early return in the CheckWebServerOriginName() function within webserver.js when self-signed certificates are in use. Attackers can open cross-origin WebSocket connections to any of the twelve WebSocket endpoints, send crafted action commands to exfiltrate the server sessionKey used to sign session cookies, forge session tokens as arbitrary users, and gain full remote control of all managed devices governed by the MeshCentral instance.
The GOOSE parser contains an off-by-one boundary-handling flaw that can be triggered by a single unauthenticated Layer-2 multicast frame on the process bus. When specific GOOSE message fields are processed, the parser advances its internal buffer position incorrectly, resulting in a heap out-of-bounds read. On affected platforms, this condition reliably terminates the subscriber process and causes a denial-of-service.
The GOOSE payload parser contains a boundary handling flaw that can be triggered by a single unauthenticated Layer 2 multicast frame on the process bus. When processing specific payload fields, an attacker controlled inner element length may exceed its enclosing length, causing the parser to over read by one byte. This out-of-bounds read reliably terminates the subscriber process, resulting in a denial-of-service condition.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.